Effectdossier · gearchiveerd kwartaal
CLDX
Celldex Therapeutics, Inc. · Healthcare · Biotechnology
17Gevolgde houders
0Δ houders
35.45MGehouden aandelen
$917.00MGerapporteerde waarde
+0Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +0.8% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +8 | 50.70M | $1.89B | +11 | −3 |
| Q1 2026 | 82 | +10 | 42.54M | $1.35B | +12 | −2 |
| Q4 2025 | 72 | 0 | 42.78M | $1.16B | — | — |
| Q3 2025 | 17 | 0 | 35.45M | $917.00M | — | — |
| Q2 2025 | 14 | 0 | 33.46M | $680.97M | — | — |
| Q1 2025 | 11 | -1 | 21.24M | $385.48M | — | −1 |
| Q4 2024 | 12 | +1 | 21.78M | $550.46M | +2 | −1 |
| Q3 2024 | 10 | -1 | 17.69M | $601.30M | — | −1 |
| Q2 2024 | 11 | — | 17.48M | $646.94M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 2 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.80M | +10.8% | $150.05M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 5.51M | -0.8% | $142.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 4.96M | -8.8% | $128.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 4.96M | -8.8% | $128.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 4.96M | -8.8% | $128.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 4.96M | -8.8% | $128.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passief) | 3.95M | -0.1% | $102.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | The Vanguard Group ✦ (passief) | 3.95M | -0.1% | $102.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | The Vanguard Group ✦ (passief) | 3.95M | -0.1% | $102.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | The Vanguard Group ✦ (passief) | 3.95M | -0.1% | $102.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | The Vanguard Group ✦ (passief) | 3.95M | -0.1% | $102.31M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Point72 Asset Management ✦ | 3.89M | +39.0% | $100.74M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 33 | State Street Global Advisors ✦ (passief) | 2.84M | +18.1% | $73.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | T. Rowe Price ✦ | 2.38M | -37.6% | $61.64M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 2.38M | -37.6% | $61.64M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | Geode Capital Management ✦ (passief) | 1.65M | -1.5% | $42.62M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | Geode Capital Management ✦ (passief) | 1.65M | -1.5% | $42.62M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | Goldman Sachs Group ✦ | 1.03M | — | $26.63M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Goldman Sachs Group ✦ | 1.03M | — | $26.63M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Millennium Management ✦ | 975.20K | +104.3% | $25.23M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | Fisher Asset Management ✦ | 927.16K | +12.8% | $23.99M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 369.55K | — | $9.56M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 369.55K | — | $9.56M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 369.55K | — | $9.56M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 369.55K | — | $9.56M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Citadel Advisors ✦ | 319.33K | -15.7% | $8.26M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | Citadel Advisors ✦ | 319.33K | -15.7% | $8.26M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 311.92K | — | $8.07M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | D. E. Shaw & Co. ✦ | 257.33K | -60.1% | $6.66M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 57 | D. E. Shaw & Co. ✦ | 257.33K | -60.1% | $6.66M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 58 | Renaissance Technologies ✦ | 194.59K | +7.3% | $5.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 59 | Two Sigma Investments ✦ | 73.40K | -9.1% | $1.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 227 houders, 72.32M aandelen, $2.21B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API